Epigallocatechin-3-gallate decreases the transport and metabolism of simvastatin in rats

References

• Chen C, Mireles RJ, Campbell SD, et al (2005). Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. Drug Metab Dispos 33:537–46
   PubMed Web of Science ®Google Scholar
• Chung JH, Choi DH, Choi JS. (2009). Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos 30:90–3
   PubMed Web of Science ®Google Scholar
• Draganov DI, Stetson PL, Watson CE, et al (2000). Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275:33435–42
   PubMed Web of Science ®Google Scholar
• Farabegoli F, Papi A, Bartolini G, et al (2010). (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 17:356–62
   PubMed Web of Science ®Google Scholar
• Fuchikami H, Satoh H, Tsujimoto M, et al (2006). Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 34:577–82
   PubMed Web of Science ®Google Scholar
• Ge J, Tan BX, Chen Y, et al (2011). Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. J Mol Med (Berl) 89:595–602
   PubMed Web of Science ®Google Scholar
• Golden EB, Lam PY, Kardosh A, et al (2009). Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 113:5927–37
   PubMed Web of Science ®Google Scholar
• Khan N, Mukhtar H. (2007). Tea polyphenols for health promotion. Life Sci 81:519–33
   PubMed Web of Science ®Google Scholar
• Knop J, Misaka S, Singer K, et al (2015). Inhibitory effects of green tea and (-)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-glycoprotein. PLoS One 10:e0139370
   PubMed Web of Science ®Google Scholar
• Kunze A, Huwyler J, Camenisch G, et al (2014). Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data . Drug Metab Dispos 42:1514–21
   PubMed Web of Science ®Google Scholar
• Lee JH, Jeong YJ, Lee SW, et al (2010). EGCG induces apoptosis in human laryngeal epidermoid carcinoma Hep2 cells via mitochondria with the release of apoptosis-inducing factor and endonuclease G. Cancer Lett 290:68–75
   PubMed Web of Science ®Google Scholar
• Li C, Choi JS. (2008). Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats. Pharmazie 63:815–18
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Neuvonen M, Neuvonen PJ. (2004). Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol 58:56–60
   PubMed Web of Science ®Google Scholar
• Misaka S, Kawabe K, Onoue S, et al (2013). Green tea extract affects the cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats. Drug Metab Pharmacokinet 28:514–18
   PubMed Web of Science ®Google Scholar
• Murtaza G. (2012). Solubility enhancement of simvastatin: a review. Acta Pol Pharm 69:581–90
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Ariyoshi N, Kotani A, et al (2004). Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinet 19:280–9
   PubMedGoogle Scholar
• Pasanen MK, Neuvonen M, Neuvonen PJ, et al (2006). SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenet Genomics 16:873–9
   PubMed Web of Science ®Google Scholar
• Prueksaritanont T, Subramanian R, Fang X, et al (2002). Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. Drug Metab Dispos 30:505–12
   PubMed Web of Science ®Google Scholar
• Prueksaritanont T, Ma B, Yu N. (2003). The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. Br J Clin Pharmacol 56:120–4
   PubMed Web of Science ®Google Scholar
• Qian F, Wei D, Zhang Q, et al (2005). Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells. Biomed Pharmacother 59:64–9
   PubMed Web of Science ®Google Scholar
• Roth M, Timmermann BN, Hagenbuch B. (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 39:920–6
   PubMed Web of Science ®Google Scholar
• Singh BN, Shankar S, Srivastava RK. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82:1807–21
   PubMed Web of Science ®Google Scholar
• Shin SC, Choi JS. (2009). Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs 20:584–8
   PubMed Web of Science ®Google Scholar
• Shitara Y, Maeda K, Ikejiri K, et al (2013). Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. Biopharm Drug Dispos 34:45–78
   PubMed Web of Science ®Google Scholar
• Thangapazham RL, Singh AK, Sharma A, et al (2007). Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 245:232–41
   PubMed Web of Science ®Google Scholar
• Wang X, Wolkoff AW, Morris ME. (2005). Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos 33:1666–72
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu HJ, Markowitz JS. (2015). Carboxylesterase 1-Mediated drug-drug interactions between clopidogrel and simvastatin. Biol Pharm Bull 38:292–7
   PubMed Web of Science ®Google Scholar
• Wanwimolruk S, Wong K, Wanwimolruk P. (2009). Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metab Drug Interact 24:17–36
   PubMedGoogle Scholar
• Werba JP, Giroli M, Cavalca V, et al (2008). The effect of green tea on simvastatin tolerability. Ann Intern Med 149:286–7
   PubMed Web of Science ®Google Scholar
• Yang CS, Wang X, Lu G, et al (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–39
   PubMed Web of Science ®Google Scholar
• Yang CS, Pan E. (2012). The effects of green tea polyphenols on drug metabolism. Expert Opin Drug Metab Toxicol 8:677–89
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang J, Du Y, et al (2016). The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells. Tumour Biol. [Epub ahead of print]. doi: 10.1007/s13277-015-4719-x
   Web of Science ®Google Scholar
• Zhu K, Wang W. (2015). Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1. Tumour Biol. . [Epub ahead of print]. doi: 10.1007/s13277-015-4187-3
   Web of Science ®Google Scholar